Upgrade to SI Premium - Free Trial

Dyne Therapeutics (DYN) PT Lowered to $30 at RBC Capital Following NVS Setback

September 9, 2026 7:23 AM
(Updated - September 9, 2026 7:53 AM EDT)

RBC Capital analyst Luca Issi lowered the price target on Dyne ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change